Ligand validation:5HXQ

O4B: 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE

O4B is a Ligand Of Interest in 5HXQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HXQ_O4B_C_402	11%	56%	0.232	0.743	0.78	0.92	-	-	2	0	100%	1
5HXQ_O4B_C_401	6%	58%	0.324	0.76	0.86	0.77	-	-	0	0	100%	1
5HXP_O4B_C_402	46%	57%	0.161	0.896	0.84	0.82	-	-	0	0	100%	1
5HXT_O4B_B_404	7%	57%	0.23	0.674	0.73	0.91	-	-	0	0	100%	1
7JY1_O4B_B_203	95%	96%	0.067	0.972	0.16	0.2	-	-	0	0	100%	1
3WUR_O4B_B_202	94%	44%	0.067	0.964	1.23	0.96	1	1	0	0	100%	1
5ZW2_O4B_A_503	92%	64%	0.08	0.969	0.59	0.78	-	-	0	0	100%	1
7JY3_O4B_B_203	91%	97%	0.073	0.959	0.16	0.17	-	-	0	0	100%	1
6AF6_O4B_A_503	90%	72%	0.084	0.965	0.63	0.47	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.